Embody, a cultivate(MD) portfolio company, is receiving a $2.5 million Phase II Small Business Innovation Research award through the Defense Advanced Research Projects Agency (DARPA).
Virtual Incision, a cultivate(MD) portfolio company, announced today that it has closed announced it has raised $20 million in a Series B+ financing.
A medical device startup in the region has received FDA clearance for a new product.
Genesis is proud to be a sponsor of the 2020 ASAP Meeting (Advanced Shoulder ArthroPlasty). This year’s meeting will be held on January 16-18, 2020 in Snowbird, UT.
Congratulations to Ward Detwiler, who was just awarded as a Crain’s Top 40 Under 40!
Rob Ball, CEO of Genesis Innovation Group will be a Keynote Panelist at OMTEC 2019.
HOLLAND, Mich., April 18th, 2019—Genesis Innovation Group’s Shoulder Innovations (SI) is focused on human centered design.
HOLLAND, Mich., April 11, 2019 — Genesis Innovation Group and their cultivate(MD) Capital Fund I and cultivate(MD) Capital Fund II, LP, funds focused on investments into early stage healthcare companies …
HOLLAND, Mich., March 4th, 2019– Genesis Innovation Group’s cultivate(MD) Capital Fund II, LP, a fund focused on investments into early stage healthcare companies with innovative technologies, announces its investment into …
Genesis will be hosting a special Workshop at the 2019 ASAP Meeting.